Bluejay Diagnostics Inc BJDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.58
- Day Range
- $0.54–0.60
- 52-Week Range
- $0.39–13.98
- Bid/Ask
- $0.52 / $0.58
- Market Cap
- $1.56 Mil
- Volume/Avg
- 14,732 / 53,488
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.bluejaydx.com
Valuation
|
Metric
|
BJDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.25 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BJDX
|
|---|---|
Quick Ratio | 1.25 |
Current Ratio | 1.82 |
Interest Coverage | — |
Quick Ratio
BJDX
Profitability
|
Metric
|
BJDX
|
|---|---|
Return on Assets (Normalized) | −106.11% |
Return on Equity (Normalized) | −138.72% |
Return on Invested Capital (Normalized) | −133.06% |
Return on Assets
BJDX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rlpwmqbw | Mtpxy | $181.1 Bil | |
SYK
| Stryker Corp | Mldphdvyj | Rmx | $127.5 Bil | |
MDT
| Medtronic PLC | Yvwchpzx | Phxpm | $113.7 Bil | |
BSX
| Boston Scientific Corp | Mflkgzsrf | Wvpcyd | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Shsjfznmk | Crtmv | $54.3 Bil | |
DXCM
| DexCom Inc | Kxdwprkhp | Gvkq | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Stwdyvmg | Rxztqgy | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mznjcfzmw | Jdtq | $24.7 Bil | |
ALGN
| Align Technology Inc | Xnxmpfwj | Rhjfj | $20.6 Bil | |
PODD
| Insulet Corp | Kwjtsbnbwp | Xnqdjv | $13.1 Bil |